Renal Cancer - Results from #5240

Renal Medullary Carcinoma; A Rare Entity April 5, 2017

miR-10b is a prognostic marker in clear cell renal cell carcinoma April 5, 2017

Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma April 4, 2017

Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment April 4, 2017

Whole-genome analysis of papillary kidney cancer finds significant noncoding alterations April 4, 2017

[Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 24 cases] April 4, 2017

PD-L2: A prognostic marker in chromophobe renal cell carcinoma? April 4, 2017

LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma April 4, 2017

ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma April 4, 2017

Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of (99m)Tc-sestamibi SPECT/CT April 3, 2017

Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma April 3, 2017

Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients April 3, 2017

Urologic Oncologic Survey Robotic level III inferior vena cava tumor thrombectomy: Initial series. April 3, 2017

Laparoscopic cryoablation for renal cell carcinoma: 100-Month oncologic outcomes. April 2, 2017

Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Upstaged to T3a April 1, 2017

Interconnection: A qualitative analysis of adjusting to living with renal cell carcinoma April 1, 2017

Final overall survival analysis for the phase II RECORD-3 Study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC March 31, 2017

Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor-Resistant Clear Cell Renal Cell Carcinoma March 31, 2017

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma March 31, 2017

Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study March 30, 2017

Page 263 of 456